• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Warfarin: an inconvenient truth.

作者信息

Gattellari Melina, Worthington John, Zwar Nicholas

出版信息

Stroke. 2009 Jan;40(1):5-7. doi: 10.1161/STROKEAHA.108.527903. Epub 2008 Aug 28.

DOI:10.1161/STROKEAHA.108.527903
PMID:18757283
Abstract
摘要

相似文献

1
Warfarin: an inconvenient truth.华法林：一个难以忽视的真相。
Stroke. 2009 Jan;40(1):5-7. doi: 10.1161/STROKEAHA.108.527903. Epub 2008 Aug 28.
2
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.心房颤动中卒中预防与出血风险之间的平衡：重新审视这一微妙平衡
Stroke. 2008 May;39(5):1406-8. doi: 10.1161/STROKEAHA.107.506832. Epub 2008 Mar 6.
3
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.老年房颤患者的直接凝血酶抑制与卒中预防：来自SPORTIF III和V试验的经验
Stroke. 2007 Nov;38(11):2965-71. doi: 10.1161/STROKEAHA.107.488007. Epub 2007 Sep 20.
4
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.华法林在房颤患者中的净临床获益：来自瑞典房颤队列研究的报告。
Circulation. 2012 May 15;125(19):2298-307. doi: 10.1161/CIRCULATIONAHA.111.055079. Epub 2012 Apr 18.
5
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.与华法林相比，希美加群预防全身性栓塞和中风的疗效。一项推算安慰剂分析。
Cardiovasc Drugs Ther. 2005 Mar;19(2):149-51. doi: 10.1007/s10557-005-3405-4.
6
Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.非瓣膜性心房颤动患者的长期凝血酶原时间国际标准化比值（PT-INR）水平与临床事件：特别提及低强度华法林治疗
J Cardiol. 2014 Aug;64(2):127-32. doi: 10.1016/j.jjcc.2013.11.015. Epub 2014 Jan 17.
7
Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.用于心房颤动患者预防卒中的新型口服抗凝药。
Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006.
8
Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.非瓣膜性心房颤动抗凝患者年龄与中风及死亡的关系：AMADEUS试验
Stroke. 2015 Nov;46(11):3202-7. doi: 10.1161/STROKEAHA.115.010614. Epub 2015 Oct 13.
9
Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?临床问题。对于非瓣膜性心房颤动患者，联合使用阿司匹林和华法林是否能降低中风风险？
J Fam Pract. 2004 Jul;53(7):570-5.
10
Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?非瓣膜性心房颤动患者华法林治疗的个体化决策：基因检测和影像学筛查如何发挥作用？
Stroke. 2008 Dec;39(12):3308-15. doi: 10.1161/STROKEAHA.108.523159. Epub 2008 Oct 9.

引用本文的文献

1
A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.老年人使用药物管理途径的抗凝剂安全性综述：权衡利弊。
Ther Adv Drug Saf. 2011 Apr;2(2):45-58. doi: 10.1177/2042098611400495.
2
Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes.老年患者口服抗凝药用于心源性栓塞性卒中的二级预防
Int Arch Med. 2010 Jun 5;3:8. doi: 10.1186/1755-7682-3-8.
3
Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.
华法林敏感性基因分型：文献回顾和患者经验总结。
Mayo Clin Proc. 2009 Dec;84(12):1079-94. doi: 10.4065/mcp.2009.0278.